| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 37794-48-2 | Acetamide,N-[4-(cyclohexylmethyl)cyclohexyl]-, trans- (9CI); N-ACETYL-4-CYCLOHEXYLMETHYLCYCLOHEXYLAMINE |  | C15H27NO | 詳情 | 供應商 | |
| 37794-87-9 | Acetamide,N-[4-(cyclohexylmethyl)cyclohexyl]-, cis- (9CI); N-Acetyl-cis-4-(cyclohexylmethyl)cyclohexamine; cis-N-[4-(Cyclohexylmethyl)cyclohexyl]acetamide |  | C15H27NO | 詳情 | 供應商 | |
| 64755-15-3 | Methanone, (2-ethyl-1-piperidinyl)(2-methylcyclohexyl)-; Piperidine, 2-ethyl-1-[(2-methylcyclohexyl)carbonyl]-(9CI); AI3-36560 |  | C15H27NO | 詳情 | 供應商 | |
| 28939-61-9 | Pentanamide,N-methyl-N-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]-; Valeramide,N-methyl-N-[(3-methyl-2-norbornyl)methyl]- (8CI) |  | C15H27NO | 詳情 | 供應商 | |
| 39027-76-4 | Pyrido[2,1,6-de]quinolizin-2-ol,1-ethyldodecahydro-9a-methyl-, [1S-(1a,2b,3ab,6ab,9ab)]- (9CI); Poranthericine |  | C15H27NO | 詳情 | 供應商 | |
| 165877-92-9 | 1-Propanone,1-[(3R,5S,8aR)-3-butyloctahydro-5-indolizinyl]-; 1-Propanone,1-(3-butyloctahydro-5-indolizinyl)-, [3R-(3a,5b,8aa)]-; (-)-Myrmicarin 237A; Myrmicarine 237A |  | C15H27NO | 詳情 | 供應商 | |
| 165877-93-0 | 1-Propanone,1-[(3R,5R,8aR)-3-butyloctahydro-5-indolizinyl]-; 1-Propanone,1-(3-butyloctahydro-5-indolizinyl)-, [3R-(3a,5a,8aa)]-; Myrmicarine 237B |  | C15H27NO | 詳情 | 供應商 | |
| 39027-77-5 | 2H-[1,3]Oxazino[2,3,4-de]quinolizine,decahydro-9a-methyl-2-propyl-, (2R,3aS,6aS,9aS)-; 2H-[1,3]Oxazino[2,3,4-de]quinolizine,decahydro-9a-methyl-2-propyl-, [2R-(2a,3ab,6aa,9ab)]-; (-)-Porantheridine; Porantheridine |  | C15H27NO | 詳情 | 供應商 |